Synthetic cannabinoids are a class of drugs designed to have similar structures and biological activities as the psychoactive components in cannabis. This encompasses a wide range of structural variants, and their potencies and toxicities are not fully understood. This trade publication piece summarizes the history of synthetic cannabinoids and highlights the ongoing challenge they present to public health and interdiction efforts.
Downloads
Similar Publications
- A novel loop-mediated isothermal amplification method for identification of four body fluids with smartphone detection
- Prevalence and risk of psychiatric disorders as a function of variant rape histories: results from a national survey of women
- Prevalence of Neurodevelopmental, Mental, and Behavioral Disorders in a Sample of U.S. Commercially Sexually Exploited Youth, and Associations with Health and Health Care Access